FN1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL14421357	0.77	4/20
SCHEMBL13046704	0.71	4/20
SCHEMBL14279932	0.68	4/20
SCHEMBL14279940	0.68	4/20
SCHEMBL13046700	0.65	4/20
SCHEMBL14279946	0.65	4/20
SCHEMBL14421326	0.60	4/20
SCHEMBL14279951	0.54	4/20
SCHEMBL14587051	0.52	4/20
SCHEMBL16144717	0.51	4/20
SCHEMBL15848778	0.64	3/20
SCHEMBL14342409	0.63	3/20
SCHEMBL15848776	0.55	3/20
SCHEMBL14172588	0.54	3/20
SCHEMBL15848764	0.52	3/20
SCHEMBL15848914	0.51	3/20
SCHEMBL14342382	0.50	3/20
SCHEMBL14342410	0.49	3/20
SCHEMBL13046711	0.38	3/20
SCHEMBL15848769	0.52	1/20

Clinical trials — most relevant to FN1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD	PHASE4	UNKNOWN
Arthroscopy and Manipulation vs a Home Therapy Program in the Treatment of Adhesive Capsulitis	PHASE4	COMPLETED
Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.	PHASE3	COMPLETED
A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma	PHASE3	COMPLETED
Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2	PHASE3	COMPLETED
Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor	PHASE1	COMPLETED
Multi-omics Study of Peritoneal Dialysis Effluent to Explore Biomarkers of Peritoneal Fibrosis	nan	NOT_YET_RECRUITING
Pathology, Venous Disease, and Clinical Correlations	nan	UNKNOWN
Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell Carcinoma	nan	UNKNOWN
Tracking the Natural Course of Silent Small Bowel Narrowing in Adults With Crohn's Disease	nan	COMPLETED
Prospective Monocentric Clinical-biological Database	nan	RECRUITING
Evaluation of Irisin Levels in Adult Forearm Fracture Surgery Under Infraclavicular Block and General Anesthesia	nan	NOT_YET_RECRUITING
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer	nan	RECRUITING
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion	nan	COMPLETED
Biomarkers in the Diagnosis and Prognosis of NAFLD	nan	RECRUITING
Role of Nox2 in CNI-induced Renal Fibrosis	nan	COMPLETED
Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognitive Impairment	nan	NOT_YET_RECRUITING
Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis	nan	RECRUITING
Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions	nan	UNKNOWN
Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection	nan	UNKNOWN
Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib Treatment	nan	COMPLETED
Fibrotic Focus in Breast Cancer	nan	UNKNOWN
Angiotensin II Antagonism of TGF-Beta 1	nan	COMPLETED
Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion	nan	UNKNOWN
PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study	nan	NOT_YET_RECRUITING
Ventricular Matrix Remodeling: Correlates and Prognosis	nan	COMPLETED
Comparison of Topical Use of Platelet-rich Plasma Versus Hyaluronic Acid During Endoscopic Fat Graft Myringoplasty: a Randomized Clinical Study	nan	NOT_YET_RECRUITING
The Influence of Daily Grapes Intake on Sarcopenia in Postmenopausal Women	nan	COMPLETED
Development of a Wearable Device for Osteoporosis Prevention and Fracture Risk Reduction in Women	nan	ENROLLING_BY_INVITATION
Arterial Composition and Cardiovascular Outcome in DIabeteS	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a FN1 binder may also engage these)

Protein	Name	Similarity
Q28749	—	1.000	Q28749 →
P07589	—	1.000	P07589 →
Q28275	—	1.000	Q28275 →
Q91740	—	1.000	Q91740 →
Q28377	—	0.999	Q28377 →
P04937	—	0.998	P04937 →
P11276	—	0.998	P11276 →
P11722	—	0.997	P11722 →
P14543	—	0.987	P14543 →
Q91400	—	0.983	Q91400 →
P10493	—	0.983	P10493 →
Q7TQN3	—	0.981	Q7TQN3 →
Q14118	—	0.981	Q14118 →
Q90344	—	0.980	Q90344 →
Q66K08	—	0.980	Q66K08 →
Q80YX1	—	0.979	Q80YX1 →
O42422	—	0.979	O42422 →
Q03145	—	0.979	Q03145 →
PTPRM	Receptor-type tyrosine-protein phosphatase mu	0.979	landscape →
O61307	—	0.979	O61307 →
A0M8R7	—	0.979	A0M8R7 →
Q94128	—	0.978	Q94128 →
G4V4G1	—	0.978	G4V4G1 →
O60687	—	0.978	O60687 →
A6H737	—	0.978	A6H737 →
O18016	—	0.978	O18016 →
Q09YH7	—	0.978	Q09YH7 →
O77469	—	0.978	O77469 →
Q98TB4	—	0.978	Q98TB4 →
P61135	—	0.978	P61135 →